Studies to improve clinical care of Sturge-Weber Syndrome
New Drug Screening Program for Sturge-Weber Syndrome
Following the exciting discovery at the Kennedy Krieger Institute of the somatic mutation in the GNAQ gene causing Sturge-Weber syndrome, we have developed lab-based research to test novel drugs in cells with the mutation. This new program will likely provide important new treatment strategies for testing in the future. Funding is urgently needed to maintain and expand this groundbreaking work. If you would like to become more involved, please contact Jen Doyle in the Office of Philanthropy at 443-923-4324 or make your gift online.
New Clinical Drug Trials For Sturge-Weber Syndrome
We completed recruitment for our first clinical drug trial in Sturge-Weber syndrome and are currently analyzing the data we have collected so far. Planning for a second trial is underway. This new study will open soon, so contact Dr. Comi at 443-923-9127 or Sturgeweber@kennedykrieger.org for more information or to find out how you can help.
NA_00038014, BVMC 6202: Innovative approaches to gauge progression of Sturge-Weber Syndrome - Renewal 1 Projects
Sturge-Weber Center at the Kennedy Krieger Institute has received a second round of funding from the Brain Vascular Malformation Consortium (BVMC). The BVMC is a collection of academic medical centers, patient support groups, and clinical research resources dedicated to conducting clinical research on different forms of brain vascular malformations, including Sturge-Weber syndrome (SWS).
Aim 1 -
1a) Standardized Sturge-Weber syndrome registry and clinical database. A centralized database and registry is needed to better understand Sturge-Weber syndrome and foster future clinical research. This national database is de-identified and housed at the University of South Florida. We have reached approximately 42% of our enrollment goal as of March 2016 and plan to continue enrollment with the help of our recruiting sites. We are beginning to analyze data collected to date.
1b) Urine Biomarkers in Sturge-Weber syndrome. This project continues to collect urine samples from those with Sturge-Weber syndrome and family members. Urine has the potential to be an indicator for disease progression when compared to family members. Differences among gender, age, extent of port-wine stain, and severity of clinical neurological functioning have been discovered based on different urine biomarker factors. As of March 2016, we have reached approximately 16% of our enrollment goal for participants with Sturge-Weber syndrome and 25% of our enrollment goal for family members.
1c) Imaging of the eye in Sturge-Weber syndrome. Optical coherence tomography (OCT) images the tissue lining in the back of the eye using light waves, a clinical indication of eye prognosis in Sturge-Weber syndrome. We are currently recruiting participants for this aim.
Aim 2 – Imaging of the brain in Sturge-Weber syndrome. Neuroimaging scans provide a detailed view into the inner workings of Sturge-Weber syndrome brain involvement. We have reached approximately 47% of our total enrollment goal as of March 2016. We will continue to actively recruit from our imaging database.
Aim 3 – Tissue Sampling in Sturge-Weber syndrome. In skin and brain tissue of those with Sturge-Weber syndrome, there is a mix of mutant and non-mutant cells. Since our discovery of the SWS-gene mutation, our new detection method has the ability to help identify only the cells with the SWS-causing somatic mutation. As of March 2016, we have reached approximately 49% of our total enrollment goal for brain tissue and seek to begin enrollment of those with Port-wine birthmarks (PWB), collecting both PWB tissue and non-PWB tissue.
NA_00043846, BVMC 6204: Establishing reliability for Quantitative EEG, Transcranial Doppler, behavioral outcomes, and Optical Coherence Tomography in SWS
Our goal is to develop methods to improve early diagnosis, to monitor response to treatment, and to predict functional outcome of SWS.
Aim 1 - Quantitative EEG. Diagnosing brain involvement in infants with a facial Port-wine birthmark is complicated by the low sensitivity of neuroimaging at young age. qEEG may be a useful biomarker for SWS brain involvement, especially for young patients, as an alternative to MRIs or CTs. Recruitment from this study is complete and data analysis is ongoing.
Aim 2 - Transcranial Doppler. Asymmetry in blood flow velocity, as seen on transcranial Doppler ultrasounds, may correlate with neurologic progression. Transcranial Doppler ultrasound holds promise in assessing the risk of stroke among SWS patients. Recruitment for this study is complete and data analysis is ongoing.
Aim 3 - Medical Rehabilitation Scales. Hemiparesis and fine motor skills are often problematic for SWS patients. A variety of clinical medical rehabilitation scales, may help assess functional skills and mobility issues among SWS patients. These scales may serve as practical methods for evaluating SWS progression and response to treatment.
This study is complete and the following manuscript has been published:
Reidy TG, Suskauer SJ, Bachur CD, McCollough C, Comi AM. Preliminary Reliability and Validity of a Battery for Assessing Functional Skills in Children with Sturge-Weber Syndrome. Childs Nerv Syst. 2014;30:2027-36. doi: 10.1007/s00381-014-2573-6
Aim 4 - Optical Coherence Tomography. Glaucoma is associated with the presence of a Port-wine facial birthmark around the eye region. Optical coherence tomography is a non-invasive measure that could prove useful in assessing eye pressure in SWS.
This study is complete and the following manuscript has been published: Karun SA, Quigley HA, Comi A, Rhonda BM, Jampel. Increased Choroidal Thickness in Patients with Sturge-Weber Syndrome. JAMA Opthalmology. 2013;131:1216-9. doi: 10.1001/jamaophthalmol.2013.4044
Clinical EEG's and their correlations
We seek to uncover the way clinical EEG reading is associated with our monitoring of SWS clinical outcomes.
Noninvasive Imaging and Functional Correlation of Intracranial Pial Angiomatosis in Patients With Sturge-Weber Syndrome
Principal Investigator: Doris Lin, MD, PhD
Co-investigators: Anne Comi, M.D. & Peter Barker, D. Phil.
This study is an important component in our work to discover better ways to use MRI imaging to diagnose and monitor Sturge-Weber syndrome.
Children (age 8 and greater) and adults with Sturge-Weber syndrome: Participants have an imaging study of the brain and a neuropsychological evaluation to see how the vascular structures and blood flow are changed by Sturge-Weber syndrome.
Quantitative EEG Study
Principal Investigator: Anne Comi, MD and Joshua Ewen, M.D.
The purpose of this study is to determine whether quantitative EEG can improve early screening of SWS brain involvement in at-risk infants with a V1 facial port-wine birthmark and to determine if it will help us safely monitor response to treatment.
We have been developing quantitative EEG (see our initial study in the completed study section) as a safe tool to screen infants with a facial Port-wine birthmark for brain involvement and for monitoring neurologic progression. This involves a routine EEG that is analyzed in a special way to evaluate for abnormal asymmetry in power. Recruitment for this study is complete and data analysis is ongoing.
Doppler and ultrasound studies of the eye in Sturge-Weber syndrome
Principal Investigator: Anne Comi, MD
The purpose of this study is to develop the optimal use of Doppler and ultrasound for the understanding of abnormal blood flow in the eye and for monitoring progression in SWS.
This study is retrospectively reviewing the results of Doppler and ultrasound studies done as part of the clinical evaluation of patients with SWS and eye involvement. Analyzing these studies in large numbers of patients with SWS will improve our understanding of the blood flow dynamics in the eye and how they change over time and in response to treatment.
We have published the following manuscript related to Doppler: Jordan LC, Wityk RJ, Dowling MM, DeJong MR, Comi AM. Transcranial Doppler ultrasound in children with Sturge-Weber syndrome. J Child Neurol. 2008 Feb;23(2):137-43.
Principal Investigator: Anne Comi, MD and Andrew Zabel, Ph.D.
The purpose of this study is to better delineate the range of cognitive deficits in SWS and understand how this is associated with the extent of brain involvement and other neurologic issues.
This testing is designed to measure how well a person performs on various tasks, including memory, language, attention, and learning. Some tests may involve writing or saying the answers to questions. Other tests may involve drawing pictures or performing tasks like putting objects in order.
Studies to better understand the pathogenesis (cause) of Spurge-Weber Syndrome
These studies are conducted as part of The Sturge-Weber Syndrome and Ischemia in the Immature Brain Research Program at Kennedy Krieger Institute.